HOME >> BIOLOGY >> NEWS
JCI Table of Contents, September 15, 2003

A cheap and easy way to treat Parkinson disease

A team of researchers, led by Serge Przedborski, at Columbia University in New York, have demonstrated that infusion of D-beta-hydroxybutyrate (D-beta-HB) to mice suffering from Parkinson disease restored impaired brain function and protected against neurodegeneration and motor skill abnormalities. D-beta-HB, already utilized in the treatment of epilepsy, may represent a cheap and easy way to treat Parkinson disease.

Parkinson disease is the second most common neurodegenerative disorder after Alzheimer disease. Sufferers experience motor skill abnormalities including tremor, muscle stiffness, and unstable voluntary movements and posture. The main pathological feature of the Parkinson brain is the loss of dopaminergic neurons.

Reported in an article in the September 15 issue of the Journal of Clinical Investigation, Przedborski and colleagues administered the neurotoxin MPTP to mice, which caused dopaminergic neurodegeneration and deficits in the mitochondrial electron transport chain reminiscent of Parkinson disease. Using this model of disease, the authors showed that the infusion of the ketone body D-beta-HB restored mitochondrial respiration and protected against MPTP-induced neurodegeneration and motor deficits. The study supports a critical role for mitochondrial defect in Parkinson disease.

Ketone bodies are already successfully used in the treatment of epilepsy. They are also able to penetrate the blood-brain barrier that often prevents potentially beneficial drugs from entering the brain.

D-beta-HB may therefore be considered as a novel form of neuroprotective therapy in the treatment of Parksinson disease.

TITLE: D-beta-Hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease

AUTHOR CONTACT:
Serge Przedborski
Columbia University, New York, New York, USA.
Phone: (212) 305-1540
Fax: (212)
'"/>

Contact: Brooke Grindlinger
science_editor@the-jci.org
212-342-9006
Journal of Clinical Investigation
15-Sep-2003


Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology news :

1. JCI Table of Contents, 15 July 2004
2. JCI Table of Contents, January 15 2004
3. JCI Table of Contents, November 3, 2003
4. JCI Table of Contents, 1 October, 2003
5. JCI Table of Contents
6. JCI Table of Contents, 15 August 2003
7. JCI Table of Contents, May 1, 2003
8. JCI Table of Contents, April 1, 2003
9. JCI Table of Contents, March 14, 2003
10. JCI Table of Contents, January 2, 2003
11. JCI Table of Contents, December 2, 2002

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/5/2018)... ... October 04, 2018 , ... ... University of Illinois Extension and Monroe County Economic Development Corporation (EDC), has ... Institute of Food and Agriculture (NIFA) Non-Land Grant College of Agriculture (NLGCA) ...
(Date:10/3/2018)... ... October 03, 2018 , ... ... commercialization of first-in-class stromal cell immunotherapies, announced that ORBCEL-M™, a second generation ... diabetes and progressive diabetic kidney disease in a four-site, pan-European Phase I/II ...
(Date:10/2/2018)... , ... October 02, 2018 , ... ... cancer research laboratory, ACEA Biosciences, The Cell Analysis Company , is excited ... specifically for immuno-oncology applications. Experimental design and data analysis for immune oncology researchers ...
Breaking Biology News(10 mins):
(Date:9/27/2018)... ... September 27, 2018 , ... Global molecular diagnostics ... that Holotype HLA and other Omixon products will be featured among nine posters ... for Histocompatibility and Immunogenetics (ASHI) in Baltimore, MD. Additionally, Omixon’s Lunch Symposium ...
(Date:9/22/2018)... ... September 20, 2018 , ... ... to announce a strategic venture. The synergistic combination of Predicine’s GeneRADAR molecular ... and comprehensive biomarker profiling to empower clinical trials in the immuno-oncology (IO) ...
(Date:9/22/2018)... ... September 21, 2018 , ... ... in tissue function, development, and pathogenesis requires tools that can rapidly and ... , Multiplexed Ion Beam Imaging by Time-Of-Flight (MIBI-TOF) detects elements from hydrogen ...
(Date:9/15/2018)... (PRWEB) , ... September 14, 2018 , ... Nationally recognized ... Dawn G. Patrick, CPA , Managing Partner of the Firm’s Nashville practice, on her ... Cherry Bekaert since 2009 and was named Managing Partner of the Firm’s Nashville ...
Breaking Biology Technology:
Cached News: